1.78
Precedente Chiudi:
$1.79
Aprire:
$1.77
Volume 24 ore:
142.37K
Relative Volume:
0.24
Capitalizzazione di mercato:
$66.81M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.81%
1M Prestazione:
-22.61%
6M Prestazione:
-3.78%
1 anno Prestazione:
-36.43%
Metagenomi Inc Stock (MGX) Company Profile
Nome
Metagenomi Inc
Settore
Industria
Telefono
(510) 871-4880
Indirizzo
5959 HORTON STREET, EMERYVILLE
Confronta MGX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MGX
Metagenomi Inc
|
1.78 | 68.31M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-05-07 | Iniziato | H.C. Wainwright | Buy |
2024-05-02 | Downgrade | JP Morgan | Overweight → Neutral |
2024-03-05 | Iniziato | BMO Capital Markets | Outperform |
2024-03-05 | Iniziato | Chardan Capital Markets | Buy |
2024-03-05 | Iniziato | JP Morgan | Overweight |
2024-03-05 | Iniziato | Jefferies | Buy |
2024-03-05 | Iniziato | TD Cowen | Outperform |
2024-03-05 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Metagenomi Inc Borsa (MGX) Ultime notizie
Is Metagenomi Inc. stock a buy or sellTrade Entry Report & Community Supported Trade Ideas - khodrobank.com
What technical models suggest about Metagenomi Inc.’s comebackPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
What high frequency data says about Metagenomi Inc.2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Technical signs of recovery in Metagenomi Inc.Quarterly Profit Review & Real-Time Buy Signal Notifications - Newser
Chart based analysis of Metagenomi Inc. trendsJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Metagenomi Inc. stock benefit from AI tech trendsJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Using Bollinger Bands to evaluate Metagenomi Inc.2025 Year in Review & High Accuracy Trade Alerts - Newser
Can trapped investors hope for a rebound in Metagenomi Inc.Entry Point & Expert Curated Trade Setup Alerts - Newser
Pattern recognition hints at Metagenomi Inc. upside2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Metagenomi Inc. stock ready for a breakout2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
Tick level data insight on Metagenomi Inc. volatilityPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
Applying Elliott Wave Theory to Metagenomi Inc.July 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
Custom strategy builders for tracking Metagenomi Inc.Quarterly Portfolio Review & Weekly Hot Stock Watchlists - Newser
Metagenomi Inc. Stock Fails to Break Resistance Traders ReactWeekly Gains Report & Daily Price Action Insights - beatles.ru
Price momentum metrics for Metagenomi Inc. explainedGap Up & Safe Swing Trade Setups - Newser
Whale Trades: Will Metagenomi Inc. outperform during market ralliesInsider Selling & Weekly Setup with ROI Potential - khodrobank.com
News impact scoring models applied to Metagenomi Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser
What Fibonacci levels say about Metagenomi Inc. reboundChart Signals & Daily Entry Point Alerts - Newser
Is Metagenomi Inc. stock poised for growth2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Can Metagenomi Inc. withstand a market correctionWeekly Trade Summary & Long-Term Safe Investment Ideas - khodrobank.com
Regression analysis insights on Metagenomi Inc. performanceJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Metagenomi, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire
Does Metagenomi Inc. show high probability of reboundWeekly Market Summary & Safe Capital Allocation Plans - Newser
Is Metagenomi Inc. forming a bullish divergenceMarket Movers & Entry Point Confirmation Signals - khodrobank.com
What is the earnings history of Metagenomi Inc.2025 Volume Leaders & AI Powered Market Trend Analysis - khodrobank.com
Metagenomi Inc. stock momentum explained2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
Momentum Indicator Shows Bearish Divergence in Metagenomi Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Metagenomi Inc. outperform tech stocks2025 AllTime Highs & Weekly Setup with High ROI Potential - khodrobank.com
Trend analysis for Metagenomi Inc. this weekTrade Risk Report & Weekly Top Gainers Trade List - Newser
Automated trading signals detected on Metagenomi Inc.Gap Up & High Accuracy Investment Signals - Newser
How high can Metagenomi Inc. stock goJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
What makes Metagenomi Inc. stock price move sharplyWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
Risk vs reward if holding onto Metagenomi Inc.Gap Up & Weekly High Conviction Ideas - Newser
Should you hold or exit Metagenomi Inc. nowProduct Launch & Real-Time Buy Signal Notifications - Newser
Metagenomi price target lowered to $11 from $12 at Chardan - MSN
Technical Heatmap Flags Metagenomi Inc. for Watch getLinesFromResByArray error: size == 0 - 클래시안
Metagenomi Inc Azioni (MGX) Dati Finanziari
Non sono disponibili dati finanziari per Metagenomi Inc (MGX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Metagenomi Inc Azioni (MGX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Wein Matthew | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
199 |
348 |
16,693 |
Noonberg Sarah B. | Chief Medical Officer |
Jun 06 '25 |
Sale |
1.75 |
5,239 |
9,168 |
109,135 |
Wapnick Pamela | Chief Financial Officer |
Jun 06 '25 |
Sale |
1.75 |
1,576 |
2,758 |
72,108 |
Thomas Brian C. | Chief Executive Officer |
Jun 06 '25 |
Sale |
1.75 |
10,785 |
18,874 |
2,517,491 |
Irish Jian | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
6,390 |
11,182 |
315,543 |
Wein Matthew | See Remarks |
Mar 05 '25 |
Sale |
1.87 |
930 |
1,744 |
9,467 |
Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):